![Verinata Health, Inc. v. Ariosa Diagnostics, Inc. United States Court of Appeals of the Federal Circuit, 2020 No. 2018-2198, 2020 WL 1970571 (Nonprecedential): Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*: Verinata Health, Inc. v. Ariosa Diagnostics, Inc. United States Court of Appeals of the Federal Circuit, 2020 No. 2018-2198, 2020 WL 1970571 (Nonprecedential): Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*:](https://www.liebertpub.com/cms/10.1089/blr.2020.29185.cmh/asset/images/medium/blr.2020.29185.cmh_figure1.jpg)
Verinata Health, Inc. v. Ariosa Diagnostics, Inc. United States Court of Appeals of the Federal Circuit, 2020 No. 2018-2198, 2020 WL 1970571 (Nonprecedential): Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*:
![Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing | BioTechniques Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing | BioTechniques](https://www.future-science.com/cms/10.2144/btn-2019-0071/asset/images/medium/figure2.gif)
Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing | BioTechniques
![Double-sided SPRI bead enrichment of nucleosomal cfDNA fragments. (A)... | Download Scientific Diagram Double-sided SPRI bead enrichment of nucleosomal cfDNA fragments. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/341813014/figure/fig2/AS:901559772782594@1591960008527/Double-sided-SPRI-bead-enrichment-of-nucleosomal-cfDNA-fragments-A-Two-volumes-of.png)